跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13,672 条关于
“Shandong Xinhua Pharmaceutical”
全部
13,672
临床试验
804
药物
1,769
机构
2,187
资讯
8,912
去年
Shandong Xinhua Pharmaceutical Receives Approval for Pentazocine
去年
Shandong Xinhua Pharmaceutical Receives Approval for Generic Cefuroxime Axetil Dispersible Tablets in China
去年
Shandong Xinhua Pharma Gains Approval for Febuxostat Tablets in China
3天前
Shandong Boan Biotechnology Receives CDE IND Clearance for BA1203
去年
Wegovy Enters Chinese Market as Obesity Rates Rise
去年
DDH Enters Chinese Market with AI Dental Diagnostic Solution 'PANO'
6个月前
Merck KGaA Deepens China Investment with €170 Million Manufacturing Expansion and Drug Development Partnership
去年
Grand Pharmaceutical's ITM-11 Phase III Trial Accepted for GEP-NETs in China
上个月
Patient Death in China Gene-Editing Trial Raises Alarms Over Regulatory Oversight and Transparency
去年
HanAll, Daewoong, and NurrOn Announce Positive Phase 1 Results for Parkinson's Disease Therapy HL192 (ATH-399A)
第 1 页，共 892 页
上一页
下一页
